Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. NetScientific's Pre-Tax Income for the
six
months ended in Jun. 2023 was €-1.91 Mil. NetScientific's Revenue for the
six
months ended in Jun. 2023 was €0.90 Mil. Therefore, NetScientific's pretax margin for the quarter that ended in Jun. 2023 was -212.71%.
The historical rank and industry rank for NetScientific's Pretax Margin % or its related term are showing as below:
STU:NTK1'
s Pretax Margin % Range Over the Past 10 Years
Min: -49676.19 Med: -1132.97 Max: -264.05
Current: -264.71
STU:NTK1's Pretax Margin % is ranked worse than 55.99% of 1027
companies
in the Biotechnology industry
Industry Median: -176.72
vs STU:NTK1: -264.71
NetScientific Pretax Margin % Historical Data
The historical data trend for NetScientific's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NetScientific's Pretax Margin %
For the Biotechnology subindustry, NetScientific's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetScientific's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NetScientific's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where NetScientific's Pretax Margin % falls into.
NetScientific Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
NetScientific's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
NetScientific Pretax Margin % Related Terms
Thank you for viewing the detailed overview of NetScientific's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:NTK1 has been successfully added to your 